NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart drug aims to ease debilitating symptoms in genetic heart condition
Disease control Recruiting nowThis study is testing whether an investigational drug called ninerafaxstat can improve symptoms and exercise ability in people with a genetic heart condition where the heart muscle is abnormally thick. About 165 participants with symptomatic non-obstructive HCM will receive eithe…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
New hope for a stiff heart: major trial tests drug to ease debilitating symptoms
Symptom relief Recruiting nowThis study is testing whether the drug sotagliflozin can improve symptoms and daily life for people living with symptomatic hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. About 500 participants will be randomly assigned to receive either the study…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC